{"id":7048,"date":"2018-03-08T15:23:57","date_gmt":"2018-03-08T15:23:57","guid":{"rendered":"https:\/\/www.olartemoure.com\/?p=7048"},"modified":"2018-03-08T15:32:07","modified_gmt":"2018-03-08T15:32:07","slug":"gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict","status":"publish","type":"post","link":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/","title":{"rendered":"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict"},"content":{"rendered":"

On 17 February 2018, a USD $2.54 billion\u00a0verdict against Gilead infringement related with Merck Hep-C patents was overturned.<\/a><\/p>\n

In the first instance judgment \u2013occurred on December 2016-, a jury declared that Gilead infringed Merck patents over its Hepatitis C Drugs, and was charged $2.54 billion.\u00a0 However, U.S. District Judge Leonard Stark has overturned the original verdict by confirming Merck\u2019s patent that was allegedly infringed on, is actually invalid.<\/p>\n","protected":false},"excerpt":{"rendered":"

On 17 February 2018, a USD $2.54 billion\u00a0verdict against Gilead infringement related with Merck Hep-C patents was overturned. In the first instance judgment \u2013occurred on December 2016-, a jury declared that Gilead infringed Merck patents over its Hepatitis C Drugs, and was charged $2.54 billion.\u00a0 However, U.S. District Judge Leonard Stark has overturned the original […]<\/p>\n","protected":false},"author":1,"featured_media":7046,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[51,116,47],"tags":[],"class_list":["post-7048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patents","category-litigation-and-adr","category-news-en"],"yoast_head":"\nGilead wins reversal of $2.54 billion hepatitis C drug patent verdict - OlarteMoure | Intellectual Property<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict\" \/>\n<meta property=\"og:description\" content=\"On 17 February 2018, a USD $2.54 billion\u00a0verdict against Gilead infringement related with Merck Hep-C patents was overturned. In the first instance judgment \u2013occurred on December 2016-, a jury declared that Gilead infringed Merck patents over its Hepatitis C Drugs, and was charged $2.54 billion.\u00a0 However, U.S. District Judge Leonard Stark has overturned the original […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-08T15:23:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-08T15:32:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2018\/03\/180301-Medicine-Lawsuit.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3840\" \/>\n\t<meta property=\"og:image:height\" content=\"2400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\"},\"headline\":\"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict\",\"datePublished\":\"2018-03-08T15:23:57+00:00\",\"dateModified\":\"2018-03-08T15:32:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/\"},\"wordCount\":77,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/180301-Medicine-Lawsuit.jpg\",\"articleSection\":[\"Patents\",\"Litigation and ADR\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/\",\"name\":\"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict - OlarteMoure | Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/180301-Medicine-Lawsuit.jpg\",\"datePublished\":\"2018-03-08T15:23:57+00:00\",\"dateModified\":\"2018-03-08T15:32:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#primaryimage\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/180301-Medicine-Lawsuit.jpg\",\"contentUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/180301-Medicine-Lawsuit.jpg\",\"width\":3840,\"height\":2400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/olartemoure.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict - OlarteMoure | Intellectual Property","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/","og_locale":"en_US","og_type":"article","og_title":"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict","og_description":"On 17 February 2018, a USD $2.54 billion\u00a0verdict against Gilead infringement related with Merck Hep-C patents was overturned. In the first instance judgment \u2013occurred on December 2016-, a jury declared that Gilead infringed Merck patents over its Hepatitis C Drugs, and was charged $2.54 billion.\u00a0 However, U.S. District Judge Leonard Stark has overturned the original […]","og_url":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2018-03-08T15:23:57+00:00","article_modified_time":"2018-03-08T15:32:07+00:00","og_image":[{"width":3840,"height":2400,"url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2018\/03\/180301-Medicine-Lawsuit.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#article","isPartOf":{"@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/"},"author":{"name":"admin","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807"},"headline":"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict","datePublished":"2018-03-08T15:23:57+00:00","dateModified":"2018-03-08T15:32:07+00:00","mainEntityOfPage":{"@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/"},"wordCount":77,"commentCount":0,"image":{"@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2018\/03\/180301-Medicine-Lawsuit.jpg","articleSection":["Patents","Litigation and ADR","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/","url":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/","name":"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict - OlarteMoure | Intellectual Property","isPartOf":{"@id":"https:\/\/olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#primaryimage"},"image":{"@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2018\/03\/180301-Medicine-Lawsuit.jpg","datePublished":"2018-03-08T15:23:57+00:00","dateModified":"2018-03-08T15:32:07+00:00","author":{"@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807"},"breadcrumb":{"@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#primaryimage","url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2018\/03\/180301-Medicine-Lawsuit.jpg","contentUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2018\/03\/180301-Medicine-Lawsuit.jpg","width":3840,"height":2400},{"@type":"BreadcrumbList","@id":"https:\/\/olartemoure.com\/en\/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict"}]},{"@type":"WebSite","@id":"https:\/\/olartemoure.com\/#website","url":"https:\/\/olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olartemoure.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/olartemoure.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/7048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=7048"}],"version-history":[{"count":0,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/7048\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media\/7046"}],"wp:attachment":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=7048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=7048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=7048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}